These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9164920)

  • 1. Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene.
    Helene M; Lake-Bullock V; Bryson JS; Jennings CD; Kaplan AM
    J Immunol; 1997 Jun; 158(11):5079-82. PubMed ID: 9164920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
    Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
    Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
    Kornblau SM; Stiouf I; Snell V; Przepiorka D; Stephens LC; Champlin R; Marini FC
    Cancer Res; 2001 Apr; 61(8):3355-60. PubMed ID: 11309292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
    Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes.
    Contassot E; Robinet E; Angonin R; Laithier V; Bittencourt M; Pavy JJ; Cahn JY; Hervé P; Tiberghien P
    Bone Marrow Transplant; 1998 Dec; 22(11):1097-102. PubMed ID: 9877273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats.
    Weijtens M; van Spronsen A; Hagenbeek A; Braakman E; Martens A
    Hum Gene Ther; 2002 Jan; 13(2):187-98. PubMed ID: 11812276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of pseudotyped lentivirus-mediated double suicide genes to allogeneic bone marrow transplantation in mice].
    Jiang YR; Chen XL; Ma DX; Liu CS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):82-6. PubMed ID: 14990045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset composition.
    Marini FC; Kornblau SM
    Bone Marrow Transplant; 1999 May; 23(9):907-15. PubMed ID: 10338046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
    Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
    Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.
    Maury S; Litvinova E; Boyer O; Benard L; Bruel S; Klatzmann D; Cohen JL
    Gene Ther; 2002 Feb; 9(3):201-7. PubMed ID: 11859423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
    Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
    Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell transduction and suicide with an enhanced mutant thymidine kinase.
    Qasim W; Thrasher AJ; Buddle J; Kinnon C; Black ME; Gaspar HB
    Gene Ther; 2002 Jun; 9(12):824-7. PubMed ID: 12040465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene.
    Drobyski WR; Morse HC; Burns WH; Casper JT; Sandford G
    Blood; 2001 Apr; 97(8):2506-13. PubMed ID: 11290616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes.
    Burt RK; Drobyski WR; Traynor AE; Link CJ
    Bone Marrow Transplant; 1999 Nov; 24(10):1043-51. PubMed ID: 10578153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
    Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A
    Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.
    Rettig MP; Ritchey JK; Prior JL; Haug JS; Piwnica-Worms D; DiPersio JF
    J Immunol; 2004 Sep; 173(6):3620-30. PubMed ID: 15356106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
    Champlin R
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.